U.S. market Closed. Opens in 2 days 1 hour 44 minutes

PACB | Pacific Biosciences of California, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue200.52M128.30M130.51M78.89M90.89M78.63M93.47M90.71M92.78M60.59M28.18M25.98M33.86M1.67M135.00K901.00K2.16M
Cost of Revenue160.18M79.27M71.65M46.33M56.31M53.53M58.81M46.55M39.33M37.19M21.76M25.04M20.83MN/AN/AN/AN/A
Gross Profit40.34M49.03M58.86M32.57M34.58M25.10M34.66M44.16M53.45M23.40M6.42M940.00K13.03M1.67M135.00K901.00K2.16M
Operating Expenses350.71M353.85M237.02M136.95M135.12M126.08M124.44M115.40M105.63M86.26M83.96M95.28M122.79M141.91M88.20M45.71M25.55M
Selling, General & Admin163.54M160.85M124.12M72.80M75.49M63.49M59.12M47.79M45.19M38.03M38.74M47.66M46.71M30.09MN/AN/AN/A
Research & Development187.17M193.00M112.90M64.15M59.63M62.59M65.32M67.62M60.44M48.23M45.22M47.62M76.08M111.82M75.88M38.00M19.22M
Other Operating Expenses32.68M7.64M93.00K2.06M1.02M848.00KN/AN/AN/AN/AN/AN/AN/AN/A12.33M7.71M6.34M
Operating Income-310.37M-304.82M-178.16M-104.39M-100.55M-100.99M-89.78M-71.24M-52.18M-62.85M-77.54M-94.34M-109.76M-140.23M-88.07M-44.81M-23.39M
Other Expenses / Income-7.79M-9.43M-96.71M133.79M16.41M848.00K-2.40M-3.13M20.48M-3.31M-1.75M-127.00K368.00K68.00K367.00K1.05M1.87M
Before Tax Income-318.16M-314.25M-274.87M29.40M-84.13M-102.56M-92.19M-74.38M-31.70M-66.16M-79.29M-94.47M-109.39M-140.17M-87.70M-43.75M-21.52M
Income Tax Expenses-11.42M-17.32M-93.65M-6.98M-6.32M848.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-306.74M-296.93M-181.22M29.40M-77.82M-102.56M-92.19M-74.38M-31.70M-66.16M-79.29M-94.47M-109.39M-140.17M-87.70M-43.75M-21.52M
Interest Expenses14.34M14.69M12.53M267.00K2.61M2.42M2.92M3.23M2.93M2.83M2.48MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding253.63M224.46M203.62M172.96M152.53M135.09M105.68M89.15M75.61M70.47M62.78M55.73M53.87M9.94M27.74M773.84K27.74M
Diluted Shares Outstanding253.63M224.55M204.14M174.97M152.53M135.09M105.68M89.15M75.61M70.47M62.78M55.73M53.87M9.94M27.74M773.84K27.74M
EBITDA-277.67M-297.18M-178.07M-102.33M-99.52M-100.14M-80.83M-67.27M-25.09M-59.11M-71.17M-87.82M-103.58M-135.01M-83.60M-40.77M-19.94M
EBITDA Margin-138.48%-231.62%-136.44%-129.71%-109.50%-127.36%-86.47%-74.15%-27.05%-97.55%-252.54%-337.97%-305.89%-8,064.87%-61,925.19%-4,524.64%-921.91%
EBIT-303.82M-299.56M-262.34M22.69M-81.52M-99.29M-89.27M-71.14M-28.77M-63.33M-76.81M-94.47M-109.39M-140.17M-87.70M-43.75M-21.52M
EBIT Margin-151.51%-233.48%-201.01%28.76%-89.69%-126.28%-95.51%-78.42%-31.01%-104.52%-272.58%-363.56%-323.03%-8,373.12%-64,965.19%-4,856.16%-994.82%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙